CompletedPhase 4

Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

Egypt300 participantsStarted 2019-07-01

Plain-language summary

The aim of this work is to study the value of GnRH antagonist subcutaneous administration as an alternative to coasting in prevention of severe OHSS and its impact on embryos quality \& the outcome of ICSI.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * infertile women * age 20-40 * at high risk for OHSS Exclusion Criteria: * refuse to participate

What they're measuring

Number of high quality embryos

Timeframe: Within 48 hours of fertilization

Trial details

NCT IDNCT03996434

SponsorClinAmygate

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-11-10

View on ClinicalTrials.gov More Ovarian Hyperstimulation Syndrome trials